Corvus Pharmaceuticals
CRVS
C$5.72
Share price
-4.14%
Change (1 day)
109.13%
Change (1 year)
Categories
Corvus Pharmaceuticals (CRVS) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : C$13.87 Million
According to Corvus Pharmaceuticals 's latest financial reports the company's total liabilities are C$13.87 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Corvus Pharmaceuticals - Total liabilities on balance sheet (from 2015 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | C$9.11 M | -44.63% |
| 2022-12-31 | C$16.45 M | 5.02% |
| 2021-12-31 | C$15.66 M | -8.18% |
| 2020-12-31 | C$17.06 M | 4.22% |
| 2019-12-31 | C$16.37 M | 52.21% |
| 2018-12-31 | C$10.75 M | -13.93% |
| 2017-12-31 | C$12.49 M | 26.54% |
| 2016-12-31 | C$9.87 M | -94.5% |
| 2015-12-31 | C$0.17 B | 1120.62% |
| 2014-12-31 | C$14.72 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | C$31.71 M | 128.62% | 🇺🇸 USA |